⌕
Insulet · PODD · Nasdaq
Tenet 61 · Solid
Compare
$147.12+1.26%Market openTenet 61 · Solid
$147.12+1.83 (+1.26%)
Market open · 15-min delayed · as of 12:39 PM ET· Nasdaq · USD

Insulet (PODD) Stock

Insulet (PODD) has a Tenet Score of 61 of 100 against 340 Healthcare peers, as of Nov 16, 2026.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Key stats

Market cap
$10.1B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
23.5×
TTM through Sep 30, 2026 · as of close, Nov 16, 2026
52-week range
126.40 – 354.88
low → high · as of close, Nov 16, 2026
Tenet Score
61/100
Solid · 340 Healthcare peers

Industry: Health Services

Insulet Corporation scores 61/100. Solid. Strongest on growth and quality, trading at 24× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
61/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
52
Quality
70
Health
47
Growth
75

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueCQualityBHealthDGrowthBMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
6.4×
Sep 30, 2026 balance sheet
P/S
3.2×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
29%
TTM through Sep 30, 2026
Operating margin
17.5%
fiscal 2025, before interest and tax
Net margin
13.4%
TTM through Sep 30, 2026
Current ratio
2.51
Sep 30, 2026 balance sheet
Net debt / EBITDA
0.5×
TTM through Sep 30, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time,…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 212 US ETFs · top wrappers by weightSee all ETFs holding PODD →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

Compare Insulet with

What sector and industry is Insulet in?

Insulet is in the Healthcare sector and the Health Services industry.

What is Insulet's Tenet Score?

Insulet's Tenet Score is 61 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.